Basic information Safety Related Supplier

ChemicalBook Product Catalog Chemical Reagents Organic reagents fatty acid 2-Bromohexadecanoic acid

1/1

2-Bromohexadecanoic acid NEW

$37.00 5mg

$59.00 10mg

$90.00 25mg

Min. Order
Purity99.90%
Cas No18263-25-7
Supply Ability10g
Update time2026-04-14

TargetMol Chemicals Inc.

TargetMol Chemicals Inc.

VIP6Y

United States

United States

show more

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	2-Bromohexadecanoic acid
CAS No	18263-25-7
EC-No
Min. Order
Purity	99.90%
Supply Ability	10g
Release date	2026/04/14

Product Introduction

Bioactivity

Name	2-Bromohexadecanoic acid
Description	2-Bromohexadecanoic acid (2-BP) is a non-metabolizable palmitate analog, an agonist of PPARδ, which acts as a palmitoylation inhibitor and inhibits DHHC-mediated palmitoylation.
In vitro	METHODS: HepG2 was treated with PA (200 µM) and 2-Bromohexadecanoic acid (25-150 µM) to examine CSC sphere morphology and number. RESULTS: 2-Bromohexadecanoic acid (25, 50 and 150 µM) significantly reduced PA-induced CSC sphere formation in HepG2 (75-150 µM and >150 µM.[1]) METHODS: ERα or ERα-Cys447Ala-transfected HeLa and HepG2 cells were pretreated with 2-Bromohexadecanoic acid (10 µM) for 30 min, then stimulated with E2 (10 nM) for 10 min, and the target protein expression levels were detected by Western Blot. RESULTS: E2 induced ERK and AKT phosphorylation in ERα-transfected HeLa and HepG2 cells. E2-induced signaling kinase activation was completely blocked without affecting the basal level of phosphorylation if the cells were pretreated with the PAT inhibitor 2-Bromohexadecanoic acid.E2 was ineffective in inducing phosphorylation of ERK and AKT in ERα-Cys447Ala mutant-transfected HeLa cells. [2]
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information	10% DMSO+40% PEG300+5% Tween 80+45% Saline : 6 mg/mL (17.89 mM), Solution. Methanol : 100 mg/mL (298.22 mM), Sonication is recommended. DMSO : 257.5 mg/mL (767.92 mM), Sonication is recommended.
Keywords	2Bromohexadecanoic acid \| 2 Bromohexadecanoic acid
Inhibitors Related	Disulfiram \| (-)-Aspartic acid \| INF 195 \| Punicalin \| Sodium metatungstate \| IRF1-IN-1 \| Ethyl pyruvate \| (E/Z)-Necrosulfonamide \| Triclabendazole \| Nigericin sodium salt \| Prosapogenin A \| IRF1-IN-2
Related Compound Libraries	Bioactive Compound Library \| Post-Translational Modification Compound Library \| Inhibitor Library \| Immunology/Inflammation Compound Library \| Bioactive Compounds Library Max \| Bioactive Lipid Compound Library

show more

Company Profile Introduction

You may like

Recommended supplier

Send Inquriy